Dabigatran, the first alternative to the age-old anticoagulant warfarin, is coming under increased scrutiny due to reports of increased risk of cardiac events according to The Lancet. A few months ago, trauma surgeons wrote in The New England Journal of Medicine about patients on dabigatran dying needlessly from internal bleeding after trauma, such as car accidents, because the only way to reverse its effect is by hemodialysis, which is not usually available on an emergency basis in community hospitals.
Leave a Reply